Frangulin b

CAS: 14101-04-3

Ref. 3D-FF137779

Produktinformation

• Name: Frangulin b
• Synonyme: 3-(<span class="text-smallcaps">D</smallcap>-Apio-β-<smallcap>D</span>-furanosyloxy)-1,8-dihydroxy-6-methyl-9,10-anthracenedione, 3-(D-Apio-beta-D-furanosyloxy)-1,8-dihydroxy-6-methylanthraquinone, 3-{[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydrofuran-2-yl]oxy}-1,8-dihydroxy-6-methylanthracene-9,10-dione, 4,5-Dihydroxy-7-Methyl-9,10-Dioxo-9,10-Dihydroanthracen-2-Yl Pentofuranoside, 6-O-(D-Apiofuranosyl)-1,6,8-trihydroxy-3-methylanthraquinone, 9,10-Anthracenedione, 3-(<span class="text-smallcaps">D</smallcap>-apio-β-<smallcap>D</span>-furanosyloxy)-1,8-dihydroxy-6-methyl-, 9,10-Anthracenedione, 3-(D-apio-β-D-furanosyloxy)-1,8-dihydroxy-6-methyl-, 3-(D-Apio-β-D-furanosyloxy)-1,8-dihydroxy-6-methyl-9,10-anthracenedione, Frangulin B

Beschreibung

Frangulin b is a natural compound that belongs to the glycoside derivatives and has been shown to be a Cox-2 inhibitor. It inhibits the production of inflammatory cytokines by rat neutrophils, which may be due to its ability to inhibit the target enzymes cyclooxygenase-1 and -2 (COX-1, COX-2). Frangulin b also has an effect on collagen synthesis through its ability to inhibit COX-1, COX-2, and thromboxane synthase. In addition, frangulin b was shown to have anti-inflammatory properties in an animal model of arthritis.

• Marke: Biosynth

Chemische Eigenschaften

• Reinheit: Min. 95%